Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dabur India Ltd. Earnings Release 2026

Apr 3, 2026

59077_rns_2026-04-03_cb732efc-5654-4c73-aac5-c1decaa884c8.pdf

Earnings Release

Open in viewer

Opens in your device viewer

==> picture [86 x 82] intentionally omitted <==

Ref: SEC/SE/2026-27 Date: April 03, 2026

To, Corporate Relations Department BSE Ltd. Phiroze Jeejeebhoy Towers Dalal Street, Mumbai- 400001

BSE Scrip Code: 500096

Listing Department National Stock Exchange of India Ltd. Exchange Plaza, 5[th] Floor Plot No. C/1, G Block, Bandra Kurla Complex Bandra (E), Mumbai – 400051

NSE Scrip Symbol: DABUR

Sub: Quarterly Update – Q4 FY2025-26

Dear Sir/Madam,

Please find enclosed an update on the performance and demand trends witnessed during the quarter ended March 31, 2026 (Q4 FY26).

This will be followed by detailed financial results and earnings presentation once the Board of Directors of the Company approves the consolidated and standalone financial results for the quarter and Financial Year ended March 31, 2026.

Thanking you,

Yours faithfully For Dabur India Limited

Ashok Kumar Jain

Digitally signed by Ashok Kumar Jain DN: c=IN, o=Personal, title=2634, pseudonym=fzxn5h6lv9a4tm20edjrgcpks8q3o7w1, 2.5.4.20=08443b3bbbcf5f80cd46cc26add8b8bdd652 ffd20caa6b7340b03564e4b39dfa, postalCode=110092, st=Delhi, serialNumber=ecb3e1fdc2a028c70333c2d10a7e968 110c5d0645b352ed6dfd1bc6aad8147b3, cn=Ashok Kumar Jain Date: 2026.04.03 17:21:00 +05'30'

(Ashok Kumar Jain) Group Company Secretary & Chief Compliance Officer

Encl: as above

DABUR INDIA LIMITED , Punjabi Bhawan, 10, Rouse Avenue, New Delhi – 110 002, Tel.: +91 11 71206000 Fax: +91 11 23222051 Regd. Office: 8/3, Asaf Ali Road, New Delhi – 110 002 (India)

CIN: L24230DL1975PLC007908, Email: [email protected] Website: www.dabur.com

==> picture [89 x 79] intentionally omitted <==

Update for Quarter ended March 31, 2026 (Q4 FY26)

This update provides an overall summary of the performance and demand trends witnessed during the quarter ended March 31, 2026 (Q4 FY26). This will be followed by detailed financial results and earnings presentation once the Board of Directors of the Company approves the consolidated and standalone financial results for the quarter ended March 31, 2026.

The quarter ended 31st March 2026 witnessed steady momentum in the domestic India business, underpinned by a stable macroeconomic environment. This strong domestic performance helped offset challenges in our key international markets particularly Middle East, where heightened geopolitical tensions led to demand disruptions and supply chain constraints.

The India FMCG business witnessed sequential recovery in demand and is likely to record high-single digit growth.

Home & Personal care business sustained its double-digit growth trajectory and is likely to grow in mid-

teens. This growth is expected to be led by Hair Oils, Shampoo and Home Care, which are likely to record growth in twenties. Key brands which are expected to record healthy volume-led growth are Dabur Amla franchise, Vatika Shampoo, Dabur Almond, Odonil, Odomos, Meswak and Gulabari. Majority of the portfolio continued to outpace category growth and is expected to register market share gains during the quarter.

In the Healthcare vertical, Dabur Honey, Honitus, Health Juices and Hajmola franchise are expected to report

robust double-digit growth. Dabur Glucose was impacted on account of unseasonal rains in key markets in March. Overall, Healthcare business is expected to report low-single digit growth.

F&B vertical saw a sequential improvement and is expected to register low-single digit growth in the quarter .

Foods, Real Activ Juices and Coconut Water continued to clock 20%+ growth rates. Out of Home portfolio was impacted on account of unseasonal rains in key markets. Real brand continued to outpace category growth and gained market shares across Nectars, Juices and Coconut Water.

In terms of channels, organised trade including Modern trade, E-commerce and Quick commerce maintained their growth momentum alongside a steady recovery in the General Trade.

In International business, while Middle East business was impacted on account of the US-Israel- Iran conflict, our other key markets like Turkey, Bangladesh and UK performed well and continue to grow in double-digits in constant currency terms. We expect our international business to record low-single digit growth in INR terms.

Overall, we expect consolidated revenues to grow in mid-single digits with operating profit growing ahead of the topline.

Going forward, we anticipate a progressive recovery in domestic demand, driven by improving consumption trends. We remain watchful of the evolving geopolitical landscape and will continue to take proactive measures to mitigate any potential impact on our operations and cost structure.

About Dabur India Ltd

Dabur India Limited is one of India's leading FMCG Companies. Building on a legacy of quality and experience for 141 years, today 8 out of every 10 Indian households use at least one Dabur product which is a testament to the trust we have built over generations. Our portfolio today includes three INR 1000 crore brands – Dabur Amla, Dabur Red Toothpaste and Real – alongside three INR 500 crore brands and 16 brands in the INR 100-500 crore range. Today, Dabur is the 3[rd] most distributed FMCG company with 8.5 million retail outlets reach. During FY 2024-25, Dabur recorded consolidated revenue from operations of INR 12,563 crore and consolidated profit after tax of INR 1,768 crore.

For further information please contact: Isha Lamba Ayush Goyal Email: [email protected] Email: [email protected]

Disclaimer:

The statements and financials disclosed above may differ from the reported financials to reflect the real business financial performance. Some of the statements in this communication may be forward looking statements within the meaning of applicable laws and regulations. Actual results might differ substantially from those expressed or implied.